Drug Discovery Software Market OverviewThe global drug discovery software market is emerging as a high-impact segment within the life sciences technology ecosystem, driven by the urgent need for ...

An abstract depiction of data flow. CAS aims to get companies’ scientific data out of data silos and into a format that’s readable by artificial intelligence models. Credit: Shutterstock Scientific ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...

The authors propose a novel framework that embeds AI drug discovery workflows within the familiar Electronic Lab Notebook (ELN) interface, making advanced AI tools accessible to bench chemists without ...

Research involving 150 laboratory professionals shows that most labs currently operate in a so-termed ‘passive state’, using electronic laboratory notebooks (ELNs) as digital filing cabinets, or a ...

In this free webinar, see how an ecosystem-driven, AI-enabled electronic lab notebook (ELN) supports real-world, end-to-end scientific workflows. The featured speaker will share how scientific teams ...

AI is now part of everyday life in many laboratories. Yet in a surprising number of organizations, the electronic lab notebook is still used primarily as a place to record what has already happened.

Because of that, the results vary. In many cases, AI adoption is shaped just as much by the shortcomings of existing tools as by intentional design. Some labs are seeing clear, measurable improvements ...

Generative AI can process information at incredible speed, but it cannot yet think like a scientist. In biopharma R&D, its real value lies in assisting scientists, automating routine tasks, ...